Payment overview · 2025
General Payments
$89.82
2 reported records · 2 companies
Healthcare provider profile · identity verified
Dilip Kumar Elangbam, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MUNCY, PA · NPI 1326008780
Verified facts
What the public records show
CMS Open Payments records show Dilip Kumar Elangbam, MD received $89.82 in general payments during 2025 across 2 reported records.
Indivior Inc. accounted for 71.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Indivior Inc. | Unresolved — no canonical attribution shown | $63.75 | 71.0% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $26.07 | 29.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $89.82 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SUBLOCADE Normalized: sublocade |
Drug | Indivior Inc. | $63.75 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $26.07 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $26.07 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 40 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 17 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
40 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 576 | 119 |
| Eliquis | Apixaban | 498 | 61 |
| Oxycodone Hcl | Oxycodone Hcl | 460 | 45 |
| Lisinopril | Lisinopril | 443 | 103 |
| Amlodipine Besylate | Amlodipine Besylate | 436 | 92 |
| Omeprazole | Omeprazole | 405 | 86 |
| Furosemide | Furosemide | 397 | 94 |
| Potassium Chloride | Potassium Chloride | 383 | 71 |
| Levothyroxine Sodium | Levothyroxine Sodium | 369 | 77 |
| Gabapentin | Gabapentin | 293 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 284 | 66 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 268 | 47 |
| Azithromycin | Azithromycin | 262 | 89 |
| Trazodone Hcl | Trazodone Hcl | 244 | 45 |
| Sertraline Hcl | Sertraline Hcl | 215 | 34 |
| Losartan Potassium | Losartan Potassium | 211 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 211 | 49 |
| Simvastatin | Simvastatin | 209 | 52 |
| Atenolol | Atenolol | 208 | 51 |
| Lorazepam | Lorazepam | 202 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 197 | 44 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 189 | 51 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 188 | 22 |
| Prednisone | Prednisone | 188 | 73 |
| Tramadol Hcl | Tramadol Hcl | 172 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 169 | 38 |
| Hydrochlorothiazide | Hydrochlorothiazide | 166 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 157 | 26 |
| Glipizide | Glipizide | 148 | 29 |
| Pantoprazole Sodium | Pantoprazole Sodium | 144 | 31 |
| Alprazolam | Alprazolam | 142 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 139 | 25 |
| Jardiance | Empagliflozin | 135 | 19 |
| Celecoxib | Celecoxib | 130 | 23 |
| Metformin Hcl | Metformin Hcl | 128 | 33 |
| Citalopram Hbr | Citalopram Hydrobromide | 112 | 23 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 106 | 20 |
| Spironolactone | Spironolactone | 99 | 15 |
| Clonazepam | Clonazepam | 96 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 94 | 21 |
| Cephalexin | Cephalexin | 91 | 54 |
| Finasteride | Finasteride | 91 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 83 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 83 | 41 |
| Sucralfate | Sucralfate | 82 | 21 |
| Oxycontin | Oxycodone Hcl | 79 | suppressed |
| Pregabalin | Pregabalin | 79 | 15 |
| Carvedilol | Carvedilol | 77 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 76 | 20 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 74 | suppressed |
| Famotidine | Famotidine | 71 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 71 | 15 |
| Ibuprofen | Ibuprofen | 70 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 69 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 68 | 15 |
| Trulicity | Dulaglutide | 66 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 64 | 14 |
| Allopurinol | Allopurinol | 61 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 60 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 59 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 58 | 34 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 58 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 58 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 57 | suppressed |
| Restasis | Cyclosporine | 57 | suppressed |
| Mirtazapine | Mirtazapine | 56 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 54 | 13 |
| Warfarin Sodium | Warfarin Sodium | 53 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 51 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 50 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 49 | 34 |
| Xarelto | Rivaroxaban | 49 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 48 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 47 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 46 | suppressed |
| Entresto | Sacubitril/Valsartan | 46 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 45 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 45 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 14 |
| Latanoprost | Latanoprost | 45 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 43 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 43 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 43 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Ozempic | Semaglutide | 40 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 40 | 18 |
| Levetiracetam | Levetiracetam | 39 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 38 | suppressed |
| Meloxicam | Meloxicam | 38 | suppressed |
| Memantine Hcl | Memantine Hcl | 36 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 36 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 36 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 35 | suppressed |
| Fluconazole | Fluconazole | 34 | 15 |
| Ondansetron Odt | Ondansetron | 33 | 14 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 31 | suppressed |
| Nystatin | Nystatin | 31 | 22 |
| Carisoprodol | Carisoprodol | 30 | suppressed |
| Ezetimibe | Ezetimibe | 30 | suppressed |
| Mupirocin | Mupirocin | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | suppressed |
| Jantoven | Warfarin Sodium | 28 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 14 |
| Nifedipine Er | Nifedipine | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 26 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 14 |
| Baclofen | Baclofen | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 22 | suppressed |
| Lactulose | Lactulose | 22 | suppressed |
| Lumigan | Bimatoprost | 22 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 22 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 14 |
| Fentanyl | Fentanyl | 21 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 19 | suppressed |
| Gemtesa | Vibegron | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 19 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 18 | suppressed |
| Klor-Con M10 | Potassium Chloride | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 18 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 17 | suppressed |
| Haloperidol | Haloperidol | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Rybelsus | Semaglutide | 17 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Acarbose | Acarbose | 15 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Pentoxifylline | Pentoxifylline | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 12 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Acetazolamide | Acetazolamide | 13 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 13 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Letrozole | Letrozole | 13 | suppressed |
| Levocarnitine | Levocarnitine | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 11 | suppressed |
| Klayesta | Nystatin | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Rhopressa | Netarsudil Mesylate | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $89.82 · 2 records | Indivior Inc. | Ozempic, Rybelsus, SUBLOCADE | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error